High Serum Galectin-3 Level as a Potential Biomarker of Peripheral Artery Disease in Patients Undergoing Hemodialysis.

Rev Cardiovasc Med

Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 62247 Chiayi, Taiwan.

Published: April 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Galectin-3 is implicated in the pathogenesis of inflammation and atherosclerosis. Peripheral arterial disease (PAD), characterized by a reduced ankle-brachial index (ABI), is a prognostic marker for mortality in patients on hemodialysis. We investigated the relationship between serum galectin-3 levels and PAD in patients undergoing regular hemodialysis.

Methods: We carried out a cross-sectional study at a medical center, involving 92 participants. Serum galectin-3 levels were assessed by a commercially available enzyme-linked immunosorbent assay. ABI measurement was done with an automatic device based on oscillometry. Participants were categorized into two groups, normal and low ABI, based on a 0.9 cut-off point.

Results: Eighteen patients (19.6%) exhibited a low ABI. In individuals with low ABIs, we observed a greater prevalence of diabetes mellitus, elevated serum C-reactive protein (CRP) levels, increased galectin-3 levels, and lower serum creatinine levels. Furthermore, serum galectin-3 levels (odds ratio [OR]: 1.056, 95% confidence interval [CI]: 1.003-1.112, = 0.037) and CRP (per 0.1 mg/dL increment, OR: 1.195, 95% CI: 1.032-1.383, = 0.017) were identified as independent predictors of PAD. Serum galectin-3 and log-transformed CRP levels were also independently and significantly negatively correlated with the left and right ABI values.

Conclusions: Serum galectin-3 levels correlate with PAD in patients undergoing maintenance hemodialysis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11263986PMC
http://dx.doi.org/10.31083/j.rcm2504124DOI Listing

Publication Analysis

Top Keywords

serum galectin-3
24
galectin-3 levels
20
patients undergoing
12
galectin-3
8
levels
8
pad patients
8
low abi
8
crp levels
8
serum
7
patients
5

Similar Publications

Background: Acute myocardial infarction in the elderly often leads to significant left ventricular structural remodeling, which adversely affects prognosis. This study aims to evaluate the effects of intensive rosuvastatin therapy on markers of ventricular remodeling and cardiac function following percutaneous coronary intervention (PCI) in elderly patients with ST-segment elevation myocardial infarction (STEMI).

Methods: This study enrolled 100 patients aged ≥60 years with STEMI who underwent emergency PCI.

View Article and Find Full Text PDF

Myeloid-specific STAT3 deletion modulates molecular activation of hippocampal microglia without morphological remodeling.

Biochem Biophys Res Commun

August 2025

Department of Anatomy and Convergence Medical Science, College of Medicine, Institute of Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea. Electronic address:

Neuroinflammation is a key mechanism driving the onset and progression of neurological and psychiatric disorders. Although the transcription factor signal transducer and activator of transcription 3 (STAT3) is critical for immune regulation, its precise role in myeloid cells remains incompletely understood. Here, we investigated how myeloid-specific STAT3 deletion (mSTAT3KO) affects hippocampal glial responses, including microglial morphology, astrocytic lipocalin-2, serum amyloid A1/2 (SAA1/2), and oxidative stress.

View Article and Find Full Text PDF

Chronic hepatitis B (CHB) drives liver fibrosis, contributing to chronic liver disease. Galectin-3 (Gal-3), a lectin linked to inflammation and fibrosis, was investigated for its association with liver injury severity in HBeAg-negative CHB and chronic hepatitis B virus (HBV) infection (CHI) patients. We enrolled 25 CHB, 25 CHI, and 25 healthy controls.

View Article and Find Full Text PDF

Evaluation of Cardiac Biomarkers in Lambs with White Muscle Disease.

Vet Sci

August 2025

Department of Internal Medicine, Faculty of Veterinary Medicine, Erciyes University, Kayseri 38280, Türkiye.

White muscle disease (WMD) is a degenerative condition of the skeletal and/or cardiac muscle associated with selenium (Se) and/or vitamin E deficiency, which can present in acute, subacute, or chronic forms, and is most commonly observed in young, rapidly growing animals, though it may also occur in older individuals. This study aims to determine the serum concentrations of galectin-3 (Gal-3), cardiac troponin I (cTnI), and N-terminal pro-brain natriuretic peptide (NT-proBNP), as well as the activity of creatine kinase-myocardial band (CK-MB), in lambs diagnosed with WMD, and to investigate the diagnostic potential of these biomarkers in the evaluation of myocardial injury and skeletal and/or cardiac muscle necrosis associated with WMD. A total of 50 lambs, 20 healthy and 30 with WMD, were included in the study.

View Article and Find Full Text PDF

: Galectin-3 (Gal-3), a pro-inflammatory cytokine, has been implicated in atherosclerosis and adverse cardiovascular outcomes. While its role in coronary artery disease (CAD) is increasingly recognized, its association with systemic atherosclerosis remains underexplored. Objective: To investigate serum Gal-3 levels in patients with CAD and evaluate correlations between CAD severity and extra-coronary atherosclerotic involvement (carotid, femoral, and radial territories).

View Article and Find Full Text PDF